MA-ECHOSENS
Echosens , a high-technology company offering the FibroScan® family of products, is pleased to announce that it has been chosen for the “Global Thought Leaders” series broadcast on CBS News. View a short video highlighting the Company’s groundbreaking work in the development of vital medical resources, including FibroScan® , a noninvasive solution for measuring liver elasticity and fat content of the liver at the point of care.
“We’re pleased to be selected by CBS News and proud of the video created at our international headquarters in Paris which captures the essence of Echosens, including interviews with some of our top leaders and a clinician performing a FibroScan® exam with her patient,” says Dominique Legros, Group CEO, Echosens. “Reliable, accurate and affordable, FibroScan® is designed to address a growing liver disease epidemic. Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the worldwide population and as many as 6% are affected by NASH, which is expected to increase by 63% by 2030 .”
FibroScan® has been supported by over 2,500 peer reviewed publications and 70 international guidelines. FibroScan® can be performed by a trained operator (physician, nurse, medical assistant), and is covered by Medicare, Medicaid and most insurance plans.
Echosens’ also offers Fast™ —available on the myFibroScan app — a FibroScan® -based score for the identification of at-risk NASH in NAFLD patients. Fast™ is a combination of three components: two physical biomarkers: liver stiffness (LSM by VCTE™) and CAP™, plus AST, a readily available blood marker of inflammation.
Legros states, “We are proud to be part of leading healthcare organizations working at the forefront of transforming quality of life, diagnosis and treatment to excel and fuel the future.”
About Echosens
Pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan® , the non-invasive solution for comprehensive management of liver health. FibroScan® is recognized worldwide and validated by over 2,500 peer reviewed publications and 70 international guidelines. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005039/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ASN Bank Signs a Contract With HCLTech to Accelerate Digital Transformation and Enhance Customer Experience17.12.2025 14:43:00 CET | Press release
HCLTech, a leading global technology company, today announced that it has been selected as a strategic partner by ASN Bank (formerly de Volksbank), the fourth-largest retail bank in the Netherlands. As part of its new strategy ‘Simplify and Grow’, ASN Bank aims to modernise and standardise its IT architecture, which will involve consolidating IT services, simplifying the vendor landscape and building a future-ready organisation. Under the multi-year agreement, HCLTech will support ASN Bank’s enterprise applications, and streamline services through a distributed delivery model to enhance efficiency and customer experience. Michel Ruijterman, Chief Information Officer, ASN Bank: “By signing this agreement , HCLTech’s proven track record in delivering scalable, innovative solutions tailored to the financial services sector means we can now confidently press on with streamlining our business by reducing the number of existing products and aligning the underlying processes and systems under
Riskified Announces Ascend 2026: “Intelligence in Motion” for the Next Era of Ecommerce17.12.2025 14:30:00 CET | Press release
From North America to the Asia-Pacific, Ascend 2026 will bring together leaders from the fraud and risk management community to define innovation-led ecommerce growth strategies Riskified (NYSE:RSKD), the leader in AI fraud and risk management for ecommerce, has announced that its premier global summit Ascend will once again be held as a global event series in 2026. Kicking off with North America (May) and continuing to Europe (June), Australia (August), China (September), and Japan (October), Ascend will convene each region’s largest merchants, industry experts, and technology leaders to discover the latest AI advancements and innovative strategies to propel ecommerce success. “Having pioneered using AI to fight ecommerce fraud and policy abuse over the past 10+ years, it’s equally exhilarating as it is concerning to witness the dramatic impact AI and agentic commerce are making on our industry. As risk grows more complex and shopper expectations rise, fraud teams and customer experie
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting17.12.2025 13:00:00 CET | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Mr. Andrew Y. Yan and Mr. Yin Weidong (collectively, the Board), will comprise the Board of the Company until the trial listed in late April/early May 2026. The Antigua High Court decision arises from a hearing that took place on 27 October 2025, at which applicants SAIF Partners IV L.P., OrbiMed Partners Master Fund Limited and 1Globe Capital LLC each sought injunctions to confirm the composition of their respective favoured Boards, pending determination of a dispute over the outcome of the Company’s Special Shareholders Meeting on 8 July 2025 (the SSM Dispute). The hearing of the SSM Dispute has been scheduled to take place in the Antigua High Court in late April/early May 2026, with judgment to be de
Akamai and Visa Collaborate to Build Trust in Agentic Commerce17.12.2025 13:00:00 CET | Press release
Visa’s Trusted Agent Protocol to authenticate AI shopping agents and help prevent fraud across Akamai Cloud, strengthening the trust layer in agentic commerce Akamai Technologies, Inc. (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers and protects business online, today announced a strategic collaboration with Visa (NYSE: V) to bring stronger identity, user recognition, and security controls to the emerging world of agentic commerce. Through its integration of Visa’s Trusted Agent Protocol with Akamai’s edge-based behavioral intelligence, user recognition, and bot and abuse protection, the companies will deliver the identity, authentication, and fraud controls required to let merchants confidently welcome AI agents with commerce intent into their digital storefronts. As autonomous AI agents increasingly browse, compare, and purchase on behalf of consumers, merchants face a new array of challenges. Merchants must now be able to differentiate this new type of legi
Mercans Launches the World’s First AI-Powered Globally Intelligent Workforce & Leave Management Engine17.12.2025 11:50:00 CET | Press release
A Unified Platform That Converts Unevaluated Time Data into Country- and Client-Compliant Workforce Transactions in Real Time Mercans, a global leader in payroll technology, workforce management, and HR SaaS solutions, today announced the launch of its next-generation Workforce Management (WFM) and Leave Management Engine - the world’s first platform capable of evaluating unevaluated time and attendance data against any country-specific legislation and client-specific policy framework, and converting it into fully evaluated, payroll-ready time transactions. This breakthrough engine fundamentally transforms how organizations manage time, attendance, and leave across borders by eliminating manual rule interpretation, fragmented systems, and country-by-country customizations. Solving a Global Workforce Challenge Traditional time and attendance systems capture raw or unevaluated data - clock-ins, clock-outs, absences, and leave requests - but fail to interpret that data in context. The res
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom